U.S. Journalist and Media
Contact Information

The numbers listed below are for use by professional journalists and members of the media. If you are not a member of the media and need assistance, we ask that you please contact the company at
1-800-243-0127, Monday through Friday from 8:30 a.m. to 5:00 p.m., excluding holidays.

This contact information is not intended for reporting unexpected drug effects or adverse events for any Boehringer Ingelheim product. Please report any unexpected effects or product problems to the Drug Information Unit by calling 1-800-542-6257 (option 4).

U.S. Headquarters Contact Information

Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road/P.O. Box 368
Ridgefield, CT 06877
1-800-243-0127

Corporate Press & Media Inquiries

Marybeth McGuire - Corporate
203-798-4801

General Media Inquiries for Product & Pipeline

Kate O'Connor - Public Relations
203-791-6250

Atrovent^® HFA (ipratropium bromide HFA) Inhalation Aerosol
Combivent^® (ipratropium bromide and albuterol sulfate)
Spiriva^® HandiHaler^® (tiotropium bromide inhalation powder)

Lara Crissey
203-798-4740

Aptivus^® (tipranavir) capsules
Micardis^® (telmisartan) tablets
Mirapex^® (pramipexole) tablets
Viramune^® (nevirapine) tablets

Anna Moses
203-798-4638

Aggrenox^® (aspirin/ extended-release dipyridamole) capsules
Flomax^® (tamsulosin HCl) tablets

Ann Wainright
203-791-6318

International Journalists are asked to contact

Boehringer Ingelheim GmbH
Corporate Division Communications
Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany
Tel: + 49/6132/77-2093
Fax: + 49/6132/77-6601
E-mail: webmaster

© 2009 Boehringer Ingelheim Corporation or an affiliated company. All rights reserved. Use of this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' web sites. All content intended for U.S. residents only. Terms of Use and Privacy Policy.